Anteris Technologies Global's (NASDAQ:AVR - Get Free Report) lock-up period is set to end on Wednesday, June 11th. Anteris Technologies Global had issued 14,800,000 shares in its initial public offering on December 13th. The total size of the offering was $88,800,000 based on an initial share price of $6.00. After the end of Anteris Technologies Global's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.
Anteris Technologies Global Price Performance
Shares of AVR stock traded up $0.22 on Thursday, reaching $4.96. 193,179 shares of the company were exchanged, compared to its average volume of 202,791. The firm has a 50-day simple moving average of $3.88. Anteris Technologies Global has a one year low of $2.34 and a one year high of $8.79.
Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The company reported ($0.61) EPS for the quarter. On average, analysts anticipate that Anteris Technologies Global will post -2.66 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Anteris Technologies Global
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Citadel Advisors LLC purchased a new position in Anteris Technologies Global during the fourth quarter worth about $1,160,000. Altium Capital Management LLC purchased a new stake in shares of Anteris Technologies Global during the 4th quarter valued at $4,112,000. Millennium Management LLC purchased a new position in shares of Anteris Technologies Global in the 4th quarter worth about $1,748,000. Affinity Asset Advisors LLC bought a new position in shares of Anteris Technologies Global during the 4th quarter valued at approximately $1,674,000. Finally, Nantahala Capital Management LLC purchased a new stake in Anteris Technologies Global in the fourth quarter worth $9,300,000.
About Anteris Technologies Global
(
Get Free Report)
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Featured Stories
Before you consider Anteris Technologies Global, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list.
While Anteris Technologies Global currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
